Various studies have also documented the natural course of the dissected descending aorta after type A dissection. Sabik and associates, 4 examining follow-up of over 200 patients with repaired type A dissection, concluded that "residual distal dissected aorta does not decrease late survival and has a low risk of aneurysmal change and reoperation for at least 10 years." They emphasized the importance of ensuring that the entire intimal tear is resected at the time of the original procedure, even if arch replacement is required to achieve this. Crawford and associates 5 drew similar conclusions based on a 20-year follow-up of 82 patients: "Seventy percent of surviving patients with DeBakey type I dissection were free of a second aortic operation for aneurysmal dilation of the distal false channel, but this occurred in none of nine patients in whom an intimal tear in the transverse arch was included in the resection."
Is it likely that stenting the descending aorta can prevent complications of the dissected descending aorta? It is important to note that stent treatment of aneurysms, as a general modality, has yielded very discouraging midterm results This can be seen in the reports of the EUROSTAR experience, which found "excellent early results but poor durability" 6 with late rupture noted 7 and expressed "cause for concern with regard to broad application of endovascular repair." 6 In other studies as well, early experience with endovascular treatment of abdominal and thoracic aortic aneurysms appeared promising, but as midterm follow-up data are coming to light, extremely disappointing evidence is accumulating-with graft dislodgment, aneurysm expansion, and failure to prevent rupture. In the just published EVAR 2 trial,* stent techniques did not improve survival over the "no intervention" group. 8 In the case of prophylactic stent treatment for acute descending aortic dissection, the early results of the INSTEAD trial † are also very discouraging, with higher mortality in the stent-treated group. 9, 10 Therefore, Uchida and colleagues are to be congratulated for their excellent clinical results and for investigating the clinical application of their hybrid surgical/stenting procedure. However, we must not lose sight that job #1 with acute type A aortic dissection is to produce a live patient.
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Conventional resectional procedures achieve this. We cannot, at this time, recommend general application of the hybrid technique, with its incremental complexity in an already challenging situation. Furthermore, the residual dissection in the descending aorta does not seem to be quite as serious as the authors fear. Also, there appears to be little objective evidence that placement of a stent in the descending aorta will improve the relatively benign natural outlook of that segment of the vascular tree.
Panos and associates 12 reported experience with a similar hybrid surgery/endovascular technique for acute type A aortic dissection. They maintain excellent balance in their discussion, observing that ". . . one may argue the value of this procedure, which serves a prophylactic treatment while adding a supplementary risk to an already complex procedure with a high mortality rate." We agree.
